StockNews.com Lowers Royalty Pharma (NASDAQ:RPRX) to Hold
StockNews.com cut shares of Royalty Pharma (NASDAQ:RPRX – Free Report) from a buy rating to a hold rating in a research note released on Monday morning. A number of other equities analysts also recently weighed in on the stock. Morgan Stanley boosted their target price on shares of Royalty Pharma from $48.00 to $51.00 and […]
StockNews.com cut shares of Royalty Pharma (NASDAQ:RPRX – Free Report) from a buy rating to a hold rating in a research note released on Monday morning. A number of other equities analysts also recently weighed in on the stock. Morgan Stanley boosted their target price on shares of Royalty Pharma from $48.00 to $51.00 and […]
